Current Roles

Employees:
18
Revenue:
$2.8M
About
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
Ancilia Biosciences Address

null, null
United States
Ancilia Biosciences Email